Genetically encoded biosensors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9719992
SERIAL NO

14350199

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides, inter alia, genetically encoded recombinant peptide biosensors comprising analyte-binding framework portions and signaling portions, wherein the signaling portions are present within the framework portions at sites or amino acid positions that undergo a conformational change upon interaction of the framework portion with an analyte.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRIGHAM & WOMEN'S HOSPITAL INC221 LONGWOOD AVE EBRC 414 BOSTON MA 02115

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lee, Richard T Cambridge, US 50 1347
Looger, Loren Ashburn, US 21 128
Marvin, Jonathan Ashburn, US 1 16
Schreiter, Eric Ashburn, US 7 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 1, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 1, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00